SNY - Kadmon The Big Short September, 09 2021 01:22 AM Sanofi Kadmon is one of the highest shorted tickers on NASDAQ. Even a major drug approval didn't change that attitude. Sanofi is paying more than twice the current market cap to acquire KDMN. Run, baby, run. For further details see: Kadmon, The Big Short